Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/16236738

N. Engl. J. Med. 2005 Oct 20 353 16 1673-84

Download in:

View as

General Info

PMID
16236738